Comerica Bank’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.81M | Buy |
51,008
+81
| +0.2% | +$2.7K | 0.01% | 1145 |
|
|
2022
Q3 | $1.62M | Sell |
50,927
-28
| -0.1% | -$1.06K | 0.01% | 1176 |
|
|
2022
Q2 | $2.57M | Buy |
50,955
+1,701
| +3% | +$93.9K | 0.02% | 924 |
|
|
2022
Q1 | $2.82M | Buy |
49,254
+286
| +0.6% | +$15.5K | 0.02% | 928 |
|
|
2021
Q4 | $2.72M | Sell |
48,968
-1,537
| -3% | -$80K | 0.02% | 944 |
|
|
2021
Q3 | $2.51M | Sell |
50,505
-79,326
| -61% | -$3.98M | 0.02% | 1149 |
|
|
2021
Q2 | $6.79M | Buy |
129,831
+42
| +0% | +$2.02K | 0.04% | 531 |
|
|
2021
Q1 | $6.12M | Buy |
129,789
+3,770
| +3% | +$171K | 0.04% | 619 |
|
|
2020
Q4 | $6.04M | Sell |
126,019
-19,823
| -14% | -$911K | 0.04% | 586 |
|
|
2020
Q3 | $6.43M | Sell |
145,842
-7,606
| -5% | -$381K | 0.05% | 461 |
|
|
2020
Q2 | $7.9M | Sell |
153,448
-391
| -0.3% | -$20.1K | 0.06% | 322 |
|
|
2020
Q1 | $8.17M | Sell |
153,839
-1,479
| -1% | -$78.9K | 0.08% | 268 |
|
|
2019
Q4 | $9.12M | Buy |
155,318
+88
| +0.1% | +$4.89K | 0.07% | 289 |
|
|
2019
Q3 | $8.54M | Sell |
155,230
-1,228
| -0.8% | -$63.2K | 0.07% | 315 |
|
|
2019
Q2 | $8.05M | Buy |
156,458
+274
| +0.2% | +$13.7K | 0.06% | 326 |
|
|
2019
Q1 | $8.06M | Buy |
156,184
+606
| +0.4% | +$30.3K | 0.07% | 314 |
|
|
2018
Q4 | $7.53M | Buy |
155,578
+4,421
| +3% | +$218K | 0.06% | 326 |
|
|
2018
Q3 | $7.68M | Buy |
151,157
+8,144
| +6% | +$414K | 0.06% | 335 |
|
|
2018
Q2 | $7.35M | Sell |
143,013
-9,932
| -6% | -$500K | 0.05% | 408 |
|
|
2018
Q1 | $7.62M | Buy |
152,945
+4,188
| +3% | +$195K | 0.05% | 388 |
|
|
2017
Q4 | $7.19M | Sell |
148,757
-6,145
| -4% | -$284K | 0.05% | 446 |
|
|
2017
Q3 | $7.1M | Buy |
154,902
+11,621
| +8% | +$590K | 0.05% | 408 |
|
|
2017
Q2 | $7.57M | Sell |
143,281
-3,762
| -3% | -$201K | 0.06% | 375 |
|
|
2017
Q1 | $7.5M | Sell |
147,043
-1,880
| -1% | -$95.4K | 0.06% | 368 |
|
|
2016
Q4 | $7.3M | Buy |
148,923
+4,249
| +3% | +$210K | 0.06% | 353 |
|
|
2016
Q3 | $7.76M | Buy |
144,674
+7,781
| +6% | +$427K | 0.07% | 306 |
|
|
2016
Q2 | $7.6M | Buy |
136,893
+3,732
| +3% | +$197K | 0.07% | 308 |
|
|
2016
Q1 | $7.14M | Buy |
133,161
+1,503
| +1% | +$74.9K | 0.06% | 304 |
|
|
2015
Q4 | $6.49M | Buy |
131,658
+4,292
| +3% | +$219K | 0.06% | 310 |
|
|
2015
Q3 | $6.12M | Sell |
127,366
-131,637
| -51% | -$6.85M | 0.06% | 345 |
|
|
2015
Q2 | $13.5M | Buy |
259,003
+134,616
| +108% | +$7.58M | 0.06% | 336 |
|
|
2015
Q1 | $7.18M | Sell |
124,387
-104,491
| -46% | -$5.99M | 0.06% | 321 |
|
|
2014
Q4 | $12.2M | Buy |
228,878
+112,518
| +97% | +$6.29M | 0.05% | 375 |
|
|
2014
Q3 | $6.69M | Sell |
116,360
-4,421
| -4% | -$271K | 0.06% | 322 |
|
|
2014
Q2 | $8.07M | Sell |
120,781
-23,171
| -16% | -$1.57M | 0.07% | 280 |
|
|
2014
Q1 | $9.61M | Sell |
143,952
-5,431
| -4% | -$367K | 0.07% | 262 |
|
|
2013
Q4 | $9.97M | Sell |
149,383
-58,898
| -28% | -$3.82M | 0.08% | 246 |
|
|
2013
Q3 | $13.1M | Buy |
208,281
+9,392
| +5% | +$605K | 0.09% | 221 |
|
|
2013
Q2 | $12.4M | Buy |
+198,889
| New | +$12.6M | 0.1% | 203 |
|
Other funds holding GSK
JEST
AWA
Comerica Bank's GSK Position: Q4 2022 in Review
Comerica Bank increased its GSK (GSK) stake by 0.16% in Q4 2022, buying an estimated $2.7K and bringing the position to 51,008 shares worth $1.81M. The position accounts for 0.01% of the portfolio, ranked #1145.
Comerica Bank first reported a position in GSK in Q2 2013 and has held it in 39 quarters since. The position peaked at $13.5M in Q2 2015. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.
- Comerica Bank held 51,008 shares of GSK worth $1.81M as of Q4 2022.
- Comerica Bank bought 81 GSK shares in Q4 2022, an estimated $2.7K.
- GSK made up 0.01% of Comerica Bank's portfolio in Q4 2022, its #1145 holding.
- Comerica Bank first reported a position in GSK in Q2 2013 and has held it in 39 quarters since.
- Comerica Bank's GSK position peaked at $13.5M in Q2 2015.
- 813 funds tracked by Wall St. Rank held GSK as of Q4 2022.
Based on Comerica Bank's 13F filing for Q4 2022, filed 26 Jan 2023.